Next Generation Sequencing (NGS) Services Market Share, Production Value, Cost Structure, Revenue and Future Demand to 2029 – Designer Women

Data Bridge Market Research analyzes that the Next Generation Sequencing Services (NGS) market is expected to experience a CAGR of 22.00% during the forecast period. This indicates that the market value, which was USD 6,588.68 million in 2021, would reach USD 32,335.31 million by 2029. “Whole genome sequencing” dominates the typical segment of next-generation sequencing services ( NGS). market due to the increasing number of hospitals and research laboratories in developing regions and the numerous initiatives undertaken by universities, academic and research institutes and research institutes to use this technology in the identification of root causes diseases. The market report prepared by Data Bridge market research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, price analysis, and regulatory framework.

Get a sample PDF report:

Next Generation Sequencing (NGS) Services Market Competitive Landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, R&D investment, new market initiatives, global presence, locations and production facilities , production capabilities, company strengths and weaknesses, product launch, product scope and breadth, scope of application. . The data points provided above are only related to the companies’ focus on the Next Generation Sequencing (NGS) services market.

Some of the Key Players Operating in the Next Generation Sequencing (NGS) Services Market are Medtronic (Ireland), Ethicon US, LLC. (USA), Thermo Fisher Scientific Inc. (USA), Novo Nordisk A/S (Denmark), BD (USA), Stryker (USA), Boston Scientific Corporation (USA). (USA), Luminex Corporation (USA), Eurofins Scientific SE (Luxembourg), PerkinElmer, Inc. (USA), QIAGEN (Germany), Macrogen Inc. (South Korea), GENEWIZ, Inc. ( USA), Illumina, Inc. (USA), Novogene Corporation (China), Abcam plc (UK), Merck KGaA (Germany), Promega Corporation (USA), Siemens (Germany) and GATC Biotech AG (Germany), among others.

For more information on the market analysis, see the research report summary on

Scope of the Global Next Generation Sequencing (NGS) Services Market

The Next Generation Sequencing (NGS) Services Market is segmented based on type, technology, application, and end user. The growth among these segments will help you analyze low growth segments within the industries and provide users with valuable market insights and market insights to help them make strategic decisions to identify major applications of the market.


  • Targeted sequencing/gene panels
  • RNA sequencing
  • Sequencing again
  • exome sequencing
  • CHiP – Sequencing
  • Whole genome sequencing
  • Methyl sequencing
  • Other services

Based on type, the market is segmented into gene-targeted sequencing/panels, RNA sequencing, de novo sequencing, exome sequencing, chip sequencing, whole genome sequencing, methyl sequencing, and other services.


  • Sequencing by synthesis (SBS)
  • Semiconductor Ion Sequencing
  • Single Molecule Real-Time Sequencing (SMRT)
  • Nanopore sequencing

Based on technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, single molecule real-time sequencing, and nanopore sequencing.


  • Diagnostic
  • oncologists
  • reproductive health
  • Infectious diseases
  • rare genetic diseases
  • Others
  • drug discovery
  • Discovery of biomarkers
  • Microbial genetics, agriculture and animal research
  • Other Apps

Based on application, the market is segmented into diagnostics, drug discovery, biomarker discovery, microbial genetics, agriculture, animal research, and other applications.

final user

  • Academic and government institutes
  • Research centers
  • Hospitals and Clinics
  • Pharmaceutical and biotechnology companies
  • Other end users

On the basis of end user, the market is segmented into academic and government research institutes and centers, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users.

Regional Analysis/Insights of the Next Generation Sequencing (NGS) Services Market

The Next Generation Sequencing (NGS) Services Market is analyzed and market size information and trends are provided by country, type, technology, application, and end-user as listed above. Countries Covered in the Next Generation Sequencing (NGS) Services Market Report these are the United States, Canada and Mexico in North America, Germany, France, the United Kingdom, the Netherlands, Switzerland, Belgium, Russia, Italy, Spain , Turkey and the rest of Europe in Europe. , China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa South, Egypt, Israel, Rest of Middle East and Africa (MEA) as part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America South as part of Southern South America.

North America leads the market for next-generation sequencing (NGS) services owing to the strong foundation of healthcare institutions, increasing investment from key players in the growth of advanced devices, well-established distribution channels for test product manufacturers, and growing number of research activities in this region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to increase in government awareness initiatives, increase in medical tourism, growth in research activities in the region and the growing demand for quality medical care in the region. . .

The country section of the report also provides individual market impact factors and regulatory changes in the national market that affect current and future market trends. Data points such as upstream and downstream value chain analysis, technical trends and porter five force analysis, case studies are some of the indicators used to forecast the market scenario for each country. In addition, the presence and availability of global brands and the challenges they face due to significant or rare competition from local and national brands, the impact of national tariffs and trade routes are considered while providing a forecast data analysis. nationals.

Explore the full table of contents at

Related reports:

Allogeneic Stem Cell Therapy Market – Industry size, shares, trends and growth prospects

Cancer Stem Cell Therapy Market – Industry size, shares, trends and growth prospects

Stem Cell Therapy Market in North America – Industry size, shares, trends and growth prospects

European stem cell therapy market – Industry size, shares, trends and growth prospects

Asia Pacific Stem Cell Therapy Market – Industry Size, Shares, Trends and Growth Prospects

Stem Cell Therapy Market in Middle East and Africa – Industry size, shares, trends and growth prospects

Asia-Pacific Drug-Device Combo Market – Industry size, shares, trends and growth prospects

About Data Bridge Market Research:

One absolute way to predict what the future holds is to understand today’s trend!

Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting company with an unparalleled level of resilience and integrated approaches. We are committed to unearthing the best market opportunities and fostering effective information for your business to thrive in the market. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a suite of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research has over 500 analysts working across different industries. We have served over 40% of Fortune 500 companies globally and have a network of over 5,000 clients worldwide. Data Bridge knows how to create satisfied customers who rely on our services and rely on our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

Contact us:-

Data Bridge Market Research

USA: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475


Comments are closed.